APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Compounded Topical Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Compounded Topical Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173980520328 December 2025190 pages

Choose your research edition.

Industry ResearchCompounded Topical Drug Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Compounded Topical Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Compounded Topical Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Compounded Topical Drug Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Compounded Topical Drug Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Compounded Topical Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Compounded Topical Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Compounded Topical Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Compounded Topical Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Compounded Topical Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Compounded Topical Drug include Triangle Compounding Pharmacy, QuVa Pharma, PharMEDium Services, Pharmaca Integrative Pharmacy, Perrigo Company plc, PCCA (Professional Compounding Centers of America), Nephron Pharmaceuticals Corporation, Medisca and Lorraine’s Pharmacy, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Compounded Topical Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Compounded Topical Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Compounded Topical Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Compounded Topical Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Compounded Topical Drug Segment by Company

Triangle Compounding Pharmacy

QuVa Pharma

PharMEDium Services

Pharmaca Integrative Pharmacy

Perrigo Company plc

PCCA (Professional Compounding Centers of America)

Nephron Pharmaceuticals Corporation

Medisca

Lorraine’s Pharmacy

Institutional Pharmacy Solutions

Fresenius Kabi

Fagron

Custom Scripts Pharmacy

Central Admixture Pharmacy Services (CAPS)

CareFirst Specialty Pharmacy

Cantrell Drug Company

B. Braun Melsungen AG Company

Avella Specialty Pharmacy

Atlas Pharmaceuticals

Compounded Topical Drug Segment by Type

Ointments

Lotions

Cream

Gels

Compounded Topical Drug Segment by Application

Hospitals

Retail Pharmacy

Other

Compounded Topical Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Compounded Topical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Compounded Topical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Compounded Topical Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Compounded Topical Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Compounded Topical Drug industry.

Chapter 3: Detailed analysis of Compounded Topical Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Compounded Topical Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Compounded Topical Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Ointments Table 3. Key Players of Lotions Table 4. Key Players of Cream Table 3. Key Players of Gels Table 4. Global Compounded Topical Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals Table 6. Key Players of Retail Pharmacy Table 7. Key Players of Other Table 8. Global Compounded Topical Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Compounded Topical Drug Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Compounded Topical Drug Market Share by Region (2021-2026) Table 11. Global Compounded Topical Drug Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Compounded Topical Drug Market Share by Region (2027-2032) Table 13. Compounded Topical Drug Industry Trends Table 14. Compounded Topical Drug Industry Drivers Table 15. Compounded Topical Drug Industry Opportunities and Challenges Table 16. Compounded Topical Drug Industry Restraints Table 17. Global Compounded Topical Drug Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Compounded Topical Drug Revenue Market Share by Company (2021-2026) Table 19. Global Compounded Topical Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Compounded Topical Drug Key Company Head Office and Area Served Table 21. Global Compounded Topical Drug Company, Product Type & Application Table 22. Global Compounded Topical Drug Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Compounded Topical Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Compounded Topical Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Compounded Topical Drug Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Compounded Topical Drug Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Compounded Topical Drug Revenue Market Share by Type (2021-2026) Table 29. Global Compounded Topical Drug Revenue Market Share by Type (2027-2032) Table 30. Global Compounded Topical Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Compounded Topical Drug Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Compounded Topical Drug Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Compounded Topical Drug Revenue Market Share by Application (2021-2026) Table 34. Global Compounded Topical Drug Revenue Market Share by Application (2027-2032) Table 35. Triangle Compounding Pharmacy Company Information Table 36. Triangle Compounding Pharmacy Business Overview Table 37. Triangle Compounding Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Triangle Compounding Pharmacy Compounded Topical Drug Product Portfolio Table 39. Triangle Compounding Pharmacy Recent Development Table 40. QuVa Pharma Company Information Table 41. QuVa Pharma Business Overview Table 42. QuVa Pharma Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. QuVa Pharma Compounded Topical Drug Product Portfolio Table 44. QuVa Pharma Recent Development Table 45. PharMEDium Services Company Information Table 46. PharMEDium Services Business Overview Table 47. PharMEDium Services Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. PharMEDium Services Compounded Topical Drug Product Portfolio Table 49. PharMEDium Services Recent Development Table 50. Pharmaca Integrative Pharmacy Company Information Table 51. Pharmaca Integrative Pharmacy Business Overview Table 52. Pharmaca Integrative Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Pharmaca Integrative Pharmacy Compounded Topical Drug Product Portfolio Table 54. Pharmaca Integrative Pharmacy Recent Development Table 55. Perrigo Company plc Company Information Table 56. Perrigo Company plc Business Overview Table 57. Perrigo Company plc Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Perrigo Company plc Compounded Topical Drug Product Portfolio Table 59. Perrigo Company plc Recent Development Table 60. PCCA (Professional Compounding Centers of America) Company Information Table 61. PCCA (Professional Compounding Centers of America) Business Overview Table 62. PCCA (Professional Compounding Centers of America) Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. PCCA (Professional Compounding Centers of America) Compounded Topical Drug Product Portfolio Table 64. PCCA (Professional Compounding Centers of America) Recent Development Table 65. Nephron Pharmaceuticals Corporation Company Information Table 66. Nephron Pharmaceuticals Corporation Business Overview Table 67. Nephron Pharmaceuticals Corporation Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Nephron Pharmaceuticals Corporation Compounded Topical Drug Product Portfolio Table 69. Nephron Pharmaceuticals Corporation Recent Development Table 70. Medisca Company Information Table 71. Medisca Business Overview Table 72. Medisca Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Medisca Compounded Topical Drug Product Portfolio Table 74. Medisca Recent Development Table 75. Lorraine’s Pharmacy Company Information Table 76. Lorraine’s Pharmacy Business Overview Table 77. Lorraine’s Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Lorraine’s Pharmacy Compounded Topical Drug Product Portfolio Table 79. Lorraine’s Pharmacy Recent Development Table 80. Institutional Pharmacy Solutions Company Information Table 81. Institutional Pharmacy Solutions Business Overview Table 82. Institutional Pharmacy Solutions Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Institutional Pharmacy Solutions Compounded Topical Drug Product Portfolio Table 84. Institutional Pharmacy Solutions Recent Development Table 85. Fresenius Kabi Company Information Table 86. Fresenius Kabi Business Overview Table 87. Fresenius Kabi Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Fresenius Kabi Compounded Topical Drug Product Portfolio Table 89. Fresenius Kabi Recent Development Table 90. Fagron Company Information Table 91. Fagron Business Overview Table 92. Fagron Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Fagron Compounded Topical Drug Product Portfolio Table 94. Fagron Recent Development Table 95. Custom Scripts Pharmacy Company Information Table 96. Custom Scripts Pharmacy Business Overview Table 97. Custom Scripts Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Custom Scripts Pharmacy Compounded Topical Drug Product Portfolio Table 99. Custom Scripts Pharmacy Recent Development Table 100. Central Admixture Pharmacy Services (CAPS) Company Information Table 101. Central Admixture Pharmacy Services (CAPS) Business Overview Table 102. Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Product Portfolio Table 104. Central Admixture Pharmacy Services (CAPS) Recent Development Table 105. CareFirst Specialty Pharmacy Company Information Table 106. CareFirst Specialty Pharmacy Business Overview Table 107. CareFirst Specialty Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. CareFirst Specialty Pharmacy Compounded Topical Drug Product Portfolio Table 109. CareFirst Specialty Pharmacy Recent Development Table 110. Cantrell Drug Company Company Information Table 111. Cantrell Drug Company Business Overview Table 112. Cantrell Drug Company Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Cantrell Drug Company Compounded Topical Drug Product Portfolio Table 114. Cantrell Drug Company Recent Development Table 115. B. Braun Melsungen AG Company Company Information Table 116. B. Braun Melsungen AG Company Business Overview Table 117. B. Braun Melsungen AG Company Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. B. Braun Melsungen AG Company Compounded Topical Drug Product Portfolio Table 119. B. Braun Melsungen AG Company Recent Development Table 120. Avella Specialty Pharmacy Company Information Table 121. Avella Specialty Pharmacy Business Overview Table 122. Avella Specialty Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Avella Specialty Pharmacy Compounded Topical Drug Product Portfolio Table 124. Avella Specialty Pharmacy Recent Development Table 125. Atlas Pharmaceuticals Company Information Table 126. Atlas Pharmaceuticals Business Overview Table 127. Atlas Pharmaceuticals Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Atlas Pharmaceuticals Compounded Topical Drug Product Portfolio Table 129. Atlas Pharmaceuticals Recent Development Table 130. North America Compounded Topical Drug Market Size by Type (2021-2026) & (US$ Million) Table 131. North America Compounded Topical Drug Market Size by Type (2027-2032) & (US$ Million) Table 132. North America Compounded Topical Drug Market Size by Application (2021-2026) & (US$ Million) Table 133. North America Compounded Topical Drug Market Size by Application (2027-2032) & (US$ Million) Table 134. North America Compounded Topical Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Compounded Topical Drug Market Size by Country (2021-2026) Table 136. North America Compounded Topical Drug Market Size by Country (2027-2032) Table 137. Europe Compounded Topical Drug Market Size by Type (2021-2026) & (US$ Million) Table 138. Europe Compounded Topical Drug Market Size by Type (2027-2032) & (US$ Million) Table 139. Europe Compounded Topical Drug Market Size by Application (2021-2026) & (US$ Million) Table 140. Europe Compounded Topical Drug Market Size by Application (2027-2032) & (US$ Million) Table 141. Europe Compounded Topical Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Compounded Topical Drug Market Size by Country (2021-2026) Table 143. Europe Compounded Topical Drug Market Size by Country (2027-2032) Table 144. China Compounded Topical Drug Market Size by Type (2021-2026) & (US$ Million) Table 145. China Compounded Topical Drug Market Size by Type (2027-2032) & (US$ Million) Table 146. China Compounded Topical Drug Market Size by Application (2021-2026) & (US$ Million) Table 147. China Compounded Topical Drug Market Size by Application (2027-2032) & (US$ Million) Table 148. Asia Compounded Topical Drug Market Size by Type (2021-2026) & (US$ Million) Table 149. Asia Compounded Topical Drug Market Size by Type (2027-2032) & (US$ Million) Table 150. Asia Compounded Topical Drug Market Size by Application (2021-2026) & (US$ Million) Table 151. Asia Compounded Topical Drug Market Size by Application (2027-2032) & (US$ Million) Table 152. Asia Compounded Topical Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Asia Compounded Topical Drug Market Size by Country (2021-2026) Table 154. Asia Compounded Topical Drug Market Size by Country (2027-2032) Table 155. South America, Middle East & Africa Compounded Topical Drug Market Size by Type (2021-2026) & (US$ Million) Table 156. South America, Middle East & Africa Compounded Topical Drug Market Size by Type (2027-2032) & (US$ Million) Table 157. South America, Middle East & Africa Compounded Topical Drug Market Size by Application (2021-2026) & (US$ Million) Table 158. South America, Middle East & Africa Compounded Topical Drug Market Size by Application (2027-2032) & (US$ Million) Table 159. South America, Middle East & Africa Compounded Topical Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. South America, Middle East & Africa Compounded Topical Drug Market Size by Country (2021-2026) Table 161. South America, Middle East & Africa Compounded Topical Drug Market Size by Country (2027-2032) Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Compounded Topical Drug Product Image Figure 2. Global Compounded Topical Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Compounded Topical Drug Market Share by Type: 2025 VS 2032 Figure 4. Ointments Image Figure 5. Lotions Image Figure 6. Cream Image Figure 7. Gels Image Figure 8. Global Compounded Topical Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Compounded Topical Drug Market Share by Application: 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Retail Pharmacy Image Figure 12. Other Image Figure 13. Global Compounded Topical Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 15. Global Compounded Topical Drug Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Compounded Topical Drug Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Compounded Topical Drug Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Compounded Topical Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Compounded Topical Drug Revenue Market Share by Type (2021-2032) Figure 22. Global Compounded Topical Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Compounded Topical Drug Revenue Market Share by Application (2021-2032) Figure 24. North America Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 25. North America Compounded Topical Drug Market Share by Type (2021-2032) Figure 26. North America Compounded Topical Drug Market Share by Application (2021-2032) Figure 27. North America Compounded Topical Drug Market Share by Country (2021-2032) Figure 28. United States Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 29. Canada Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 31. Europe Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 32. Europe Compounded Topical Drug Market Share by Type (2021-2032) Figure 33. Europe Compounded Topical Drug Market Share by Application (2021-2032) Figure 34. Europe Compounded Topical Drug Market Share by Country (2021-2032) Figure 35. Germany Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 36. France Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 38. Italy Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 39. Russia Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 41. China Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 42. China Compounded Topical Drug Market Share by Type (2021-2032) Figure 43. China Compounded Topical Drug Market Share by Application (2021-2032) Figure 44. Asia Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 45. Asia Compounded Topical Drug Market Share by Type (2021-2032) Figure 46. Asia Compounded Topical Drug Market Share by Application (2021-2032) Figure 47. Asia Compounded Topical Drug Market Share by Country (2021-2032) Figure 48. Japan Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 52. India Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 53. Australia Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Compounded Topical Drug Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Compounded Topical Drug Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Compounded Topical Drug Market Share by Country (2021-2032) Figure 58. Brazil Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 63. UAE Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 65. Chile Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Ointments
  • Lotions
  • Cream
  • Gels
Applications
  • Hospitals
  • Retail Pharmacy
  • Other
Companies covered
  • Triangle Compounding Pharmacy
  • QuVa Pharma
  • PharMEDium Services
  • Pharmaca Integrative Pharmacy
  • Perrigo Company plc
  • PCCA (Professional Compounding Centers of America)
  • Nephron Pharmaceuticals Corporation
  • Medisca
  • Lorraine’s Pharmacy
  • Institutional Pharmacy Solutions
  • Fresenius Kabi
  • Fagron
  • Custom Scripts Pharmacy
  • Central Admixture Pharmacy Services (CAPS)
  • CareFirst Specialty Pharmacy
  • Cantrell Drug Company
  • B. Braun Melsungen AG Company
  • Avella Specialty Pharmacy
  • Atlas Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Compounded Topical Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Ointments
  5. 1.2.3 Lotions
  6. 1.2.4 Cream
  7. 1.2.5 Gels
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Compounded Topical Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Retail Pharmacy
  12. 1.3.4 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Compounded Topical Drug Growth Trends by Region
  15. 1.5.1 Global Compounded Topical Drug Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Compounded Topical Drug Market Size by Region (2021-2026)
  17. 1.5.3 Compounded Topical Drug Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Compounded Topical Drug Market Dynamics
  1. 2.1 Compounded Topical Drug Industry Trends
  2. 2.2 Compounded Topical Drug Industry Drivers
  3. 2.3 Compounded Topical Drug Industry Opportunities and Challenges
  4. 2.4 Compounded Topical Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Compounded Topical Drug Revenue by Company (2021-2026)
  2. 3.2 Global Compounded Topical Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Compounded Topical Drug Key Company Head office and Area Served
  4. 3.4 Global Compounded Topical Drug Company, Product Type & Application
  5. 3.5 Global Compounded Topical Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Compounded Topical Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Compounded Topical Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Compounded Topical Drug Tier 1, Tier 2, and Tier 3
4 Compounded Topical Drug Market by Type
  1. 4.1 Global Compounded Topical Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Compounded Topical Drug Market Size by Type (2021-2032)
  3. 4.3 Global Compounded Topical Drug Market Size Share by Type (2021-2032)
5 Compounded Topical Drug Market by Application
  1. 5.1 Global Compounded Topical Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Compounded Topical Drug Market Size by Application (2021-2032)
  3. 5.3 Global Compounded Topical Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Triangle Compounding Pharmacy
  2. 6.1.1 Triangle Compounding Pharmacy Company Information
  3. 6.1.2 Triangle Compounding Pharmacy Business Overview
  4. 6.1.3 Triangle Compounding Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Triangle Compounding Pharmacy Compounded Topical Drug Product Portfolio
  6. 6.1.5 Triangle Compounding Pharmacy Recent Developments
  7. 6.2 QuVa Pharma
  8. 6.2.1 QuVa Pharma Company Information
  9. 6.2.2 QuVa Pharma Business Overview
  10. 6.2.3 QuVa Pharma Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 QuVa Pharma Compounded Topical Drug Product Portfolio
  12. 6.2.5 QuVa Pharma Recent Developments
  13. 6.3 PharMEDium Services
  14. 6.3.1 PharMEDium Services Company Information
  15. 6.3.2 PharMEDium Services Business Overview
  16. 6.3.3 PharMEDium Services Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 PharMEDium Services Compounded Topical Drug Product Portfolio
  18. 6.3.5 PharMEDium Services Recent Developments
  19. 6.4 Pharmaca Integrative Pharmacy
  20. 6.4.1 Pharmaca Integrative Pharmacy Company Information
  21. 6.4.2 Pharmaca Integrative Pharmacy Business Overview
  22. 6.4.3 Pharmaca Integrative Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pharmaca Integrative Pharmacy Compounded Topical Drug Product Portfolio
  24. 6.4.5 Pharmaca Integrative Pharmacy Recent Developments
  25. 6.5 Perrigo Company plc
  26. 6.5.1 Perrigo Company plc Company Information
  27. 6.5.2 Perrigo Company plc Business Overview
  28. 6.5.3 Perrigo Company plc Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Perrigo Company plc Compounded Topical Drug Product Portfolio
  30. 6.5.5 Perrigo Company plc Recent Developments
  31. 6.6 PCCA (Professional Compounding Centers of America)
  32. 6.6.1 PCCA (Professional Compounding Centers of America) Company Information
  33. 6.6.2 PCCA (Professional Compounding Centers of America) Business Overview
  34. 6.6.3 PCCA (Professional Compounding Centers of America) Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 PCCA (Professional Compounding Centers of America) Compounded Topical Drug Product Portfolio
  36. 6.6.5 PCCA (Professional Compounding Centers of America) Recent Developments
  37. 6.7 Nephron Pharmaceuticals Corporation
  38. 6.7.1 Nephron Pharmaceuticals Corporation Company Information
  39. 6.7.2 Nephron Pharmaceuticals Corporation Business Overview
  40. 6.7.3 Nephron Pharmaceuticals Corporation Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Nephron Pharmaceuticals Corporation Compounded Topical Drug Product Portfolio
  42. 6.7.5 Nephron Pharmaceuticals Corporation Recent Developments
  43. 6.8 Medisca
  44. 6.8.1 Medisca Company Information
  45. 6.8.2 Medisca Business Overview
  46. 6.8.3 Medisca Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Medisca Compounded Topical Drug Product Portfolio
  48. 6.8.5 Medisca Recent Developments
  49. 6.9 Lorraine’s Pharmacy
  50. 6.9.1 Lorraine’s Pharmacy Company Information
  51. 6.9.2 Lorraine’s Pharmacy Business Overview
  52. 6.9.3 Lorraine’s Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Lorraine’s Pharmacy Compounded Topical Drug Product Portfolio
  54. 6.9.5 Lorraine’s Pharmacy Recent Developments
  55. 6.10 Institutional Pharmacy Solutions
  56. 6.10.1 Institutional Pharmacy Solutions Company Information
  57. 6.10.2 Institutional Pharmacy Solutions Business Overview
  58. 6.10.3 Institutional Pharmacy Solutions Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Institutional Pharmacy Solutions Compounded Topical Drug Product Portfolio
  60. 6.10.5 Institutional Pharmacy Solutions Recent Developments
  61. 6.11 Fresenius Kabi
  62. 6.11.1 Fresenius Kabi Company Information
  63. 6.11.2 Fresenius Kabi Business Overview
  64. 6.11.3 Fresenius Kabi Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Fresenius Kabi Compounded Topical Drug Product Portfolio
  66. 6.11.5 Fresenius Kabi Recent Developments
  67. 6.12 Fagron
  68. 6.12.1 Fagron Company Information
  69. 6.12.2 Fagron Business Overview
  70. 6.12.3 Fagron Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Fagron Compounded Topical Drug Product Portfolio
  72. 6.12.5 Fagron Recent Developments
  73. 6.13 Custom Scripts Pharmacy
  74. 6.13.1 Custom Scripts Pharmacy Company Information
  75. 6.13.2 Custom Scripts Pharmacy Business Overview
  76. 6.13.3 Custom Scripts Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Custom Scripts Pharmacy Compounded Topical Drug Product Portfolio
  78. 6.13.5 Custom Scripts Pharmacy Recent Developments
  79. 6.14 Central Admixture Pharmacy Services (CAPS)
  80. 6.14.1 Central Admixture Pharmacy Services (CAPS) Company Information
  81. 6.14.2 Central Admixture Pharmacy Services (CAPS) Business Overview
  82. 6.14.3 Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Product Portfolio
  84. 6.14.5 Central Admixture Pharmacy Services (CAPS) Recent Developments
  85. 6.15 CareFirst Specialty Pharmacy
  86. 6.15.1 CareFirst Specialty Pharmacy Company Information
  87. 6.15.2 CareFirst Specialty Pharmacy Business Overview
  88. 6.15.3 CareFirst Specialty Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 CareFirst Specialty Pharmacy Compounded Topical Drug Product Portfolio
  90. 6.15.5 CareFirst Specialty Pharmacy Recent Developments
  91. 6.16 Cantrell Drug Company
  92. 6.16.1 Cantrell Drug Company Company Information
  93. 6.16.2 Cantrell Drug Company Business Overview
  94. 6.16.3 Cantrell Drug Company Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Cantrell Drug Company Compounded Topical Drug Product Portfolio
  96. 6.16.5 Cantrell Drug Company Recent Developments
  97. 6.17 B. Braun Melsungen AG Company
  98. 6.17.1 B. Braun Melsungen AG Company Company Information
  99. 6.17.2 B. Braun Melsungen AG Company Business Overview
  100. 6.17.3 B. Braun Melsungen AG Company Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 B. Braun Melsungen AG Company Compounded Topical Drug Product Portfolio
  102. 6.17.5 B. Braun Melsungen AG Company Recent Developments
  103. 6.18 Avella Specialty Pharmacy
  104. 6.18.1 Avella Specialty Pharmacy Company Information
  105. 6.18.2 Avella Specialty Pharmacy Business Overview
  106. 6.18.3 Avella Specialty Pharmacy Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Avella Specialty Pharmacy Compounded Topical Drug Product Portfolio
  108. 6.18.5 Avella Specialty Pharmacy Recent Developments
  109. 6.19 Atlas Pharmaceuticals
  110. 6.19.1 Atlas Pharmaceuticals Company Information
  111. 6.19.2 Atlas Pharmaceuticals Business Overview
  112. 6.19.3 Atlas Pharmaceuticals Compounded Topical Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Atlas Pharmaceuticals Compounded Topical Drug Product Portfolio
  114. 6.19.5 Atlas Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Compounded Topical Drug Market Size (2021-2032)
  2. 7.2 North America Compounded Topical Drug Market Size by Type
  3. 7.2.1 North America Compounded Topical Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Compounded Topical Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Compounded Topical Drug Market Share by Type (2021-2032)
  6. 7.3 North America Compounded Topical Drug Market Size by Application
  7. 7.3.1 North America Compounded Topical Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Compounded Topical Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Compounded Topical Drug Market Share by Application (2021-2032)
  10. 7.4 North America Compounded Topical Drug Market Size by Country
  11. 7.4.1 North America Compounded Topical Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Compounded Topical Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Compounded Topical Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Compounded Topical Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Compounded Topical Drug Market Size (2021-2032)
  2. 8.2 Europe Compounded Topical Drug Market Size by Type
  3. 8.2.1 Europe Compounded Topical Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Compounded Topical Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Compounded Topical Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Compounded Topical Drug Market Size by Application
  7. 8.3.1 Europe Compounded Topical Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Compounded Topical Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Compounded Topical Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Compounded Topical Drug Market Size by Country
  11. 8.4.1 Europe Compounded Topical Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Compounded Topical Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Compounded Topical Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Compounded Topical Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Compounded Topical Drug Market Size (2021-2032)
  2. 9.2 China Compounded Topical Drug Market Size by Type
  3. 9.2.1 China Compounded Topical Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Compounded Topical Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Compounded Topical Drug Market Share by Type (2021-2032)
  6. 9.3 China Compounded Topical Drug Market Size by Application
  7. 9.3.1 China Compounded Topical Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Compounded Topical Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Compounded Topical Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Compounded Topical Drug Market Size (2021-2032)
  2. 10.2 Asia Compounded Topical Drug Market Size by Type
  3. 10.2.1 Asia Compounded Topical Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Compounded Topical Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Compounded Topical Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Compounded Topical Drug Market Size by Application
  7. 10.3.1 Asia Compounded Topical Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Compounded Topical Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Compounded Topical Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Compounded Topical Drug Market Size by Country
  11. 10.4.1 Asia Compounded Topical Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Compounded Topical Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Compounded Topical Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Compounded Topical Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Compounded Topical Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Compounded Topical Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Compounded Topical Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Compounded Topical Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Compounded Topical Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Compounded Topical Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Compounded Topical Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Compounded Topical Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Compounded Topical Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Compounded Topical Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Compounded Topical Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Compounded Topical Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Compounded Topical Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Compounded Topical Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst